{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:29:46Z","timestamp":1790112586716,"version":"4.0.1"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p><jats:italic>Burkholderia cepacia<\/jats:italic> complex is a cause of serious lung infections in people with cystic fibrosis, exhibiting extremely high levels of antimicrobial resistance. These infections are difficult to treat and are associated with high morbidity and mortality. With a notable lack of new antibiotic classes currently in development, exploring alternative antimicrobial strategies for <jats:italic>Burkholderia cepacia<\/jats:italic> complex is crucial. One potential alternative seeing renewed interest is the use of bacteriophage (phage) therapy. This review summarises what is currently known about <jats:italic>Burkholderia cepacia<\/jats:italic> complex in cystic fibrosis, as well as challenges and insights for using phages to treat <jats:italic>Burkholderia cepacia<\/jats:italic> complex lung infections.<\/jats:p>","DOI":"10.3389\/fmicb.2024.1476041","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T04:36:40Z","timestamp":1729226200000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Phage therapy to treat cystic fibrosis Burkholderia cepacia complex lung infections: perspectives and challenges"],"prefix":"10.3389","volume":"15","author":[{"given":"Jack S.","family":"Canning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Laucirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kak-Ming","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Stick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Kicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1164\/ajrccm.161.4.9907147","article-title":"Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia","volume":"161","author":"Aaron","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1600-6143.2008.02186.x","article-title":"Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex","volume":"8","author":"Alexander","year":"2008","journal-title":"Am. J. Transplant."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1111\/ajt.15503","article-title":"Early clinical experience of bacteriophage therapy in 3 lung transplant recipients","volume":"19","author":"Aslam","year":"2019","journal-title":"Am. J. Transplant."},{"key":"ref4","volume-title":"Australian cystic fibrosis data registry: Annual Report 2021","author":"Ahern","year":"2022"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1128\/IAI.71.12.7079-7086.2003","article-title":"Prophage induction and expression of prophage-encoded virulence factors in group a Streptococcus serotype M3 StrainMGAS315","volume":"71","author":"Banks","year":"2003","journal-title":"Infect. Immun."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"10078","DOI":"10.1073\/pnas.152298499","article-title":"Genome sequence of a serotype M3 strain of group a Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence","volume":"99","author":"Beres","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1126\/science.3160112","article-title":"Staphylococcal enterotoxin a is encoded by phage","volume":"229","author":"Betley","year":"1985","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1055\/s-0039-1698464","article-title":"Microbiology of cystic fibrosis airway disease","volume":"40","author":"Blanchard","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/jpids\/piac052","article-title":"Opportunistic pathogens in cystic fibrosis: epidemiology and pathogenesis of lung infection","volume":"11","author":"Blanchard","year":"2022","journal-title":"J. Pediatr. Inf. Dis. Soc."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1080\/17425247.2017.1252329","article-title":"Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections","volume":"14","author":"Bodier-Montagutelli","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"105461","DOI":"10.1016\/j.micpath.2022.105461","article-title":"Prevalence of antibiotic resistance of Pseudomonas aeruginosa in cystic fibrosis infection: a systematic review and meta-analysis","volume":"165","author":"Bonyadi","year":"2022","journal-title":"Microb. Pathog."},{"key":"ref13","first-page":"1168","volume-title":"Toxicity of colistin in cystic fibrosis patients","author":"Bosso","year":"1991"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/thx.2007.089458","article-title":"Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres","volume":"63","author":"Boussaud","year":"2008","journal-title":"Thorax"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/v11030241","article-title":"Directed in vitro evolution of therapeutic bacteriophages: the Appelmans protocol","volume":"11","author":"Burrowes","year":"2019","journal-title":"Viruses"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.fm.2019.03.025","article-title":"Mutation of a Staphylococcus aureus temperate bacteriophage to a virulent one and evaluation of its application","volume":"82","author":"Chang","year":"2019","journal-title":"Food Microbiol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1089\/phage.2021.0007","article-title":"INfrastructure for a PHAge REference database: identification of large-scale biases in the current collection of cultured phage genomes","volume":"2","author":"Cook","year":"2021","journal-title":"Phage."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/oxfordjournals.aje.a008664","article-title":"Determinants of mortality from cystic fibrosis in Canada, 1970\u20131989","volume":"143","author":"Corey","year":"1996","journal-title":"Am. J. Epidemiol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jcf.2004.01.005","article-title":"Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults","volume":"3","author":"Courtney","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.4049\/jimmunol.156.12.4570","article-title":"Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides","volume":"156","author":"Cowdery","year":"1996","journal-title":"J. Immunol."},{"key":"ref21","volume-title":"Annual data report","year":"2021"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.healun.2010.06.007","article-title":"Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience","volume":"29","author":"De Soyza","year":"2010","journal-title":"J. Heart Lung Transplant."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ppul.20553","article-title":"The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis","volume":"42","author":"Downey","year":"2007","journal-title":"Pediatr. Pulmonol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1469-0691.2010.03237.x","article-title":"Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence","volume":"16","author":"Drevinek","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40101-021-00269-7","article-title":"The determinants of survival among adults with cystic fibrosis\u2014a cohort study","volume":"40","author":"Durda-Masny","year":"2021","journal-title":"J. Physiol. Anthropol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1093\/bioinformatics\/btz258","article-title":"multiPhATE: bioinformatics pipeline for functional annotation of phage isolates","volume":"35","author":"Ecale Zhou","year":"2019","journal-title":"Bioinformatics"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-017-0279-8","article-title":"Novel antibiotic combinations proposed for treatment of Burkholderia cepacia complex infections","volume":"6","author":"El-Halfawy","year":"2017","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3390\/children9091330","article-title":"Multidrug-resistant bacteria in children and adolescents with cystic fibrosis","volume":"9","author":"Fainardi","year":"2022","journal-title":"Children"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation","volume":"17","author":"Fishman","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-015-0148-2","article-title":"Burkholderia cepacia complex: clinical course in cystic fibrosis patients","volume":"15","author":"Folescu","year":"2015","journal-title":"BMC Pulm. Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-018-0594-8","article-title":"Implementation of a successful eradication protocol for Burkholderia cepacia complex in cystic fibrosis patients","volume":"18","author":"Garcia","year":"2018","journal-title":"BMC Pulm. Med."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.3390\/jcm9123800","article-title":"Impact of Pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases","volume":"9","author":"Garcia-Clemente","year":"2020","journal-title":"J. Clin. Med."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1365-2672.2010.04863.x","article-title":"In vitro lung delivery of bacteriophages KS4-M and \u03a6KZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis","volume":"110","author":"Golshahi","year":"2011","journal-title":"J. Appl. Microbiol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/jamp.2008.0701","article-title":"Toward modern inhalational bacteriophage therapy: nebulization of bacteriophages of Burkholderia cepacia complex","volume":"21","author":"Golshahi","year":"2008","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-9-615","article-title":"Genomic sequence and activity of KS10, a transposable phage of the Burkholderia cepacia complex","volume":"9","author":"Goudie","year":"2008","journal-title":"BMC Genomics"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/mps1010006","article-title":"Practical method for isolation of phage deletion mutants","volume":"1","author":"Guti\u00e9rrez","year":"2018","journal-title":"Methods Prot."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e14041","DOI":"10.1111\/tid.14041","article-title":"Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug-resistant Burkholderia multivorans","volume":"25","author":"Haidar","year":"2023","journal-title":"Transpl. Infect. Dis."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"762","DOI":"10.7326\/0003-4819-122-10-199505150-00005","article-title":"An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy","volume":"122","author":"Hamill","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1700112","DOI":"10.1002\/bies.201700112","article-title":"Ecological and evolutionary benefits of temperate phage: what does or doesn't kill you makes you stronger","volume":"39","author":"Harrison","year":"2017","journal-title":"BioEssays"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.3390\/ijms23073513","article-title":"The effect of CFTR modulators on airway infection in cystic fibrosis","volume":"23","author":"Harvey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/537627","article-title":"Cepacia syndrome in a non-cystic fibrosis patient","volume":"2015","author":"Hauser","year":"2015","journal-title":"Case Rep. Infect. Dis."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/BF01695659","article-title":"Delay in appropriate therapy ofLegionella pneumonia associated with increased mortality","volume":"15","author":"Heath","year":"1996","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12016-009-8136-z","article-title":"Chronic granulomatous disease","volume":"38","author":"Holland","year":"2010","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"9529","DOI":"10.1002\/14651858.CD009529.pub2","article-title":"Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation","volume":"10","author":"Horsley","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fcimb.2011.00018","article-title":"Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?","volume":"1","author":"Horsley","year":"2011","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ismej.2017.16","article-title":"Lysogeny in nature: mechanisms, impact and ecology of temperate phages","volume":"11","author":"Howard-Varona","year":"2017","journal-title":"ISME J."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"108116","DOI":"10.1016\/j.biotechadv.2023.108116","article-title":"Genetic engineering of bacteriophages: key concepts, strategies, and applications","volume":"64","author":"Hussain","year":"2023","journal-title":"Biotechnol. Adv."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7883\/yoken.JJID.2014.282","article-title":"Ventilator-associated pneumonia: epidemiology and prognostic indicators of 30-day mortality","volume":"68","author":"Inchai","year":"2015","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"111221","DOI":"10.1016\/j.nut.2021.111221","article-title":"Pseudomonas aeruginosa, the type of mutation, lung function, and nutritional status in adults with cystic fibrosis","volume":"89","author":"John","year":"2021","journal-title":"Nutrition"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/thx.2003.017210","article-title":"Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis","volume":"59","author":"Jones","year":"2004","journal-title":"Thorax"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1183\/09031936.01.17202950","article-title":"Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas","volume":"17","author":"Jones","year":"2001","journal-title":"Eur. Respir. J."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijantimicag.2018.09.004","article-title":"Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review","volume":"53","author":"Kakasis","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1128\/AEM.02850-14","article-title":"Burkholderia cepacia complex phage-antibiotic synergy (PAS): antibiotics stimulate lytic phage activity","volume":"81","author":"Kamal","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"02115","DOI":"10.1128\/mBio.02115-16","article-title":"Novel \u201csuperspreader\u201d bacteriophages promote horizontal gene transfer by transformation","volume":"8","author":"Keen","year":"2017","journal-title":"MBio"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1385261","DOI":"10.3389\/fphar.2024.1385261","article-title":"Endolysin: a new antimicrobial agent against antimicrobial resistance, strategies and opportunities in overcoming the challenges of endolysin against gram-negative bacteria","volume":"15","author":"Khan","year":"2024","journal-title":"Front. Pharmacol."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jgar.2020.01.005","article-title":"Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"22","author":"Kim","year":"2020","journal-title":"J. Global Antimicrob. Resist."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"01884","DOI":"10.1128\/mBio.01884-19","article-title":"Quorum sensing and metabolic state of the host control lysogeny-lysis switch of bacteriophage T1","volume":"10","author":"Laganenka","year":"2019","journal-title":"MBio"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-6-4","article-title":"Microbiology of airway disease in a cohort of patients with cystic fibrosis","volume":"6","author":"Lambiase","year":"2006","journal-title":"BMC Infect. Dis."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/jobm.201600108","article-title":"Preliminary survey of local bacteriophages with lytic activity against multi-drug resistant bacteria","volume":"56","author":"Latz","year":"2016","journal-title":"J. Basic Microbiol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3390\/v13071331","article-title":"Advances in phage therapy: targeting the Burkholderia cepacia complex","volume":"13","author":"Lauman","year":"2021","journal-title":"Viruses"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"e04430","DOI":"10.1128\/spectrum.04430-22","article-title":"Synergistic interactions among Burkholderia cepacia complex-targeting phages reveal a novel therapeutic role for Lysogenization-capable phages","volume":"11","author":"Lauman","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1128\/AAC.04641-14","article-title":"Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model","volume":"59","author":"Lood","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/vim.2013.0128","article-title":"Phage neutralization by sera of patients receiving phage therapy","volume":"27","author":"\u0141usiak-Szelachowska","year":"2014","journal-title":"Viral Immunol."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-14-574","article-title":"Genomic characterization of JG068, a novel virulent podovirus active against Burkholderia cenocepacia","volume":"14","author":"Lynch","year":"2013","journal-title":"BMC Genomics"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1128\/JVI.01843-09","article-title":"Inactivation of Burkholderia cepacia complex phage KS9 gp41 identifies the phage repressor and generates lytic virions","volume":"84","author":"Lynch","year":"2010","journal-title":"J. Virol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-11-599","article-title":"Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex","volume":"11","author":"Lynch","year":"2010","journal-title":"BMC Genomics"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-13-223","article-title":"Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages","volume":"13","author":"Lynch","year":"2012","journal-title":"BMC Genomics"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"14501","DOI":"10.1038\/s41598-017-14797-9","article-title":"Modular endolysin of Burkholderia AP3 phage has the largest lysozyme-like catalytic subunit discovered to date and no catalytic aspartate residue","volume":"7","author":"Maciejewska","year":"2017","journal-title":"Sci. Rep."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrmicro1085","article-title":"The multifarious, multireplicon Burkholderia cepacia complex","volume":"3","author":"Mahenthiralingam","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","article-title":"Formulation, stabilisation and encapsulation of bacteriophage for phage therapy","volume":"249","author":"Malik","year":"2017","journal-title":"Adv. Colloid Interf. Sci."},{"key":"ref74","first-page":"926","article-title":"Nosocomial Burkholderia cepacia infection and colonization associated with intrinsically contaminated mouthwash--Arizona","volume":"47","author":"Matrician","year":"1998","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/cid\/ciu385","article-title":"Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis","volume":"59","author":"Mayer-Hamblett","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/v11040343","article-title":"Current state of compassionate phage therapy","volume":"11","author":"McCallin","year":"2019","journal-title":"Viruses"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1600903","DOI":"10.1183\/13993003.00903-2016","article-title":"Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies","volume":"49","author":"Montgomery","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1007\/s00203-022-02778-0","article-title":"Burkholderia orbicola sp. nov., a novel species within the Burkholderia cepacia complex","volume":"204","author":"Morales-Ru\u00edz","year":"2022","journal-title":"Arch. Microbiol."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"e16963","DOI":"10.1371\/journal.pone.0016963","article-title":"Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention","volume":"6","author":"Morello","year":"2011","journal-title":"PLoS One"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00248-021-01782-z","article-title":"An appraisal of bacteriophage isolation techniques from environment","volume":"1","author":"Nair","year":"2022","journal-title":"Microb. Ecol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"ycae082","DOI":"10.1093\/ismeco\/ycae082","article-title":"Evolutionary and coevolutionary phage training approaches enhance bacterial suppression and delay the emergence of phage resistance","volume":"4","author":"Ngiam","year":"2024","journal-title":"ISME Commun."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1574-695X.2000.tb01491.x","article-title":"Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosa to transducing bacteriophages","volume":"28","author":"Nzula","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1510\/icvts.2011.271874","article-title":"Should cystic fibrosis patients infected with Burkholderia cepacia complex be listed for lung transplantation?","volume":"13","author":"Olland","year":"2011","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/v11010018","article-title":"Clinical indications and compassionate use of phage therapy: personal experience and literature review with a focus on osteoarticular infections","volume":"11","author":"Patey","year":"2018","journal-title":"Viruses"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.ccm.2022.07.002","article-title":"Update on lung transplantation for cystic fibrosis","volume":"43","author":"Pilewski","year":"2022","journal-title":"Clin. Chest Med."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/femsre\/fuaa017","article-title":"Current challenges and future opportunities of phage therapy","volume":"44","author":"Pires","year":"2020","journal-title":"FEMS Microbiol. Rev."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s11095-014-1617-7","article-title":"Quality and safety requirements for sustainable phage therapy products","volume":"32","author":"Pirnay","year":"2015","journal-title":"Pharm. Res."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/infdis\/jiab112","article-title":"Benefits of aerosolized phages for the treatment of pneumonia due to methicillin-resistant Staphylococcus aureus: an experimental study in rats","volume":"225","author":"Prazak","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1128\/AEM.71.3.1193-1201.2005","article-title":"Species abundance and diversity of Burkholderia cepacia complex in the environment","volume":"71","author":"Ramette","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"9876","DOI":"10.1002\/14651858.CD009876.pub4","article-title":"Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis","volume":"2019","author":"Regan","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/v10060297","article-title":"Burkholderia cenocepacia prophages\u2014prevalence, chromosome location and major genes involved","volume":"10","author":"Roszniowski","year":"2018","journal-title":"Viruses"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"e00196","DOI":"10.1128\/jb.00196-23","article-title":"Bacteriophage steering of Burkholderia cenocepacia toward reduced virulence and increased antibiotic sensitivity","volume":"205","author":"Ruest","year":"2023","journal-title":"J. Bacteriol."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/978-3-319-41986-2_50","article-title":"Phage therapy collaboration and compassionate use","author":"Sacher","year":"2021","journal-title":"Bacteriophages Biol. Technol. Ther."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/cells11071243","article-title":"CFTR modulator therapies: potential impact on airway infections in cystic fibrosis","volume":"11","author":"Saluzzo","year":"2022","journal-title":"Cells"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.femsle.2005.08.011","article-title":"Isolation and characterization of bacteriophages of the Burkholderia cepacia complex","volume":"251","author":"Seed","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1128\/AAC.02388-13","article-title":"Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections","volume":"58","author":"Semler","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fcimb.2011.00027","article-title":"The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections","volume":"1","author":"Semler","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1513\/AnnalsATS.202003-204OC","article-title":"Clinical outcomes associated with Burkholderia cepacia complex infection in patients with cystic fibrosis","volume":"17","author":"Somayaji","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"e05332","DOI":"10.1128\/spectrum.05332-22","article-title":"Burkholderia contaminans bacteriophage CSP3 requires O-antigen polysaccharides for infection","volume":"11","author":"Stanton","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.healun.2015.05.003","article-title":"Clinical and demographic factors associated with post\u2013lung transplantation survival in individuals with cystic fibrosis","volume":"34","author":"Stephenson","year":"2015","journal-title":"J. Heart Lung Transplant."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"1169135","DOI":"10.3389\/fcimb.2023.1169135","article-title":"Isolation and in vitro characterization of novel S. epidermidis phages for therapeutic applications","volume":"13","author":"\u0160trancar","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.mib.2007.05.016","article-title":"Role of phages in the pathogenesis of Burkholderia, or \u2018where are the toxin genes in Burkholderia phages?\u2019","volume":"10","author":"Summer","year":"2007","journal-title":"Curr. Opin. Microbiol."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1128\/JB.188.1.255-268.2006","article-title":"Divergence and mosaicism among virulent soil phages of the Burkholderia cepacia complex","volume":"188","author":"Summer","year":"2006","journal-title":"J. Bacteriol."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/antibiotics10020145","article-title":"Pseudomonas aeruginosa resistance to bacteriophages and its prevention by strategic therapeutic cocktail formulation","volume":"10","author":"Vaitekenas","year":"2021","journal-title":"Antibiotics"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1007\/s00253-012-4294-7","article-title":"Characterization of five novel endolysins from gram-negative infecting bacteriophages","volume":"97","author":"Walmagh","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/v12060601","article-title":"A novel inducible prophage from Burkholderia vietnamiensis G4 is widely distributed across the species and has lytic activity against pathogenic Burkholderia","volume":"12","author":"Weiser","year":"2020","journal-title":"Viruses"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/s41396-023-01529-3","article-title":"Coevolution between marine Aeromonas and phages reveals temporal trade-off patterns of phage resistance and host population fitness","volume":"17","author":"Xu","year":"2023","journal-title":"ISME J."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"e03414","DOI":"10.1128\/AEM.03414-16","article-title":"A broad-host-range tailocin from Burkholderia cenocepacia","volume":"83","author":"Yao","year":"2017","journal-title":"Appl. Environ. Microbiol."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"e00850","DOI":"10.1128\/jvi.00850-23","article-title":"Phage Milagro: a platform for engineering a broad host range virulent phage for Burkholderia","volume":"97","author":"Yao","year":"2023","journal-title":"J. Virol."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1128\/AEM.02651-15","article-title":"Diversity and ecology of viruses in hyperarid desert soils","volume":"82","author":"Zablocki","year":"2016","journal-title":"Appl. Environ. Microbiol."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1128\/AAC.00954-06","article-title":"Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis","volume":"51","author":"Zhou","year":"2007","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1476041\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T04:36:44Z","timestamp":1729226204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1476041\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":111,"alternative-id":["10.3389\/fmicb.2024.1476041"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1476041","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"article-number":"1476041"}}